MRNA - Moderna, Inc.
IEX Last Trade
40.27
0.010 0.025%
Share volume: 76,848
Last Updated: Fri 27 Dec 2024 08:30:26 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$40.26
0.01
0.02%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-24 | 2023-05-04 | 2023-08-03 | 2023-11-03 | 2024-02-23 | 2024-05-02 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 26.056 B | 25.858 B | 24.125 B | 21.884 B | 19.450 B | 18.426 B | 16.729 B | 15.680 B | |
| Current Assets | 14.297 B | 13.431 B | 12.122 B | 10.599 B | 10.799 B | 10.325 B | 9.600 B | 9.661 B | |
| Inventories | 2.257 B | 1.168 B | 951.000 M | 776.000 M | 548.000 M | 270.000 M | 295.000 M | 399.000 M | |
| Other Current Assets | 871.000 M | 510.000 M | 823.000 M | 1.005 B | 692.000 M | 450.000 M | 547.000 M | 529.000 M | |
| Short Term Investments | 871.000 M | 510.000 M | 823.000 M | 1.005 B | 692.000 M | 450.000 M | 547.000 M | 529.000 M | |
| Total Receivables | 2.821 B | 1.851 B | 1.425 B | 359.000 M | 1.986 B | 1.001 B | 235.000 M | 245.000 M | |
| Current Cash | 8.348 B | 9.902 B | 8.923 B | 8.459 B | 7.573 B | 8.604 B | 8.523 B | 8.488 B | |
| Total Non-current Assets | 11.759 B | 12.427 B | 12.003 B | 11.285 B | 8.651 B | 8.101 B | 7.129 B | 6.019 B | |
| Property Plant Equipment | 2.019 B | 2.018 B | 2.018 B | 2.280 B | 1.952 B | 1.945 B | 2.063 B | 2.196 B | |
| Other Assets | 38.000 M | 988.000 M | 1.003 B | 1.052 B | 474.000 M | 519.000 M | 502.000 M | 516.000 M | |
| Intangible Assets | 0.000 | 0.000 | 48.000 M | 46.000 M | 45.000 M | 44.000 M | 43.000 M | 42.000 M | |
| Goodwill | 0.000 | 0.000 | 52.000 M | 52.000 M | 52.000 M | 52.000 M | 52.000 M | 52.000 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 26.056 B | 25.858 B | 24.125 B | 21.884 B | 19.450 B | 18.426 B | 16.729 B | 15.680 B | |
| Total liabilities | 8.064 B | 6.735 B | 5.262 B | 4.935 B | 5.995 B | 4.572 B | 3.912 B | 3.968 B | |
| Total current liabilities | 6.807 B | 4.923 B | 3.499 B | 3.123 B | 4.385 B | 3.015 B | 2.380 B | 2.363 B | |
| Accounts Payable | 330.000 M | 487.000 M | 389.000 M | 310.000 M | 494.000 M | 520.000 M | 183.000 M | 279.000 M | |
| Other liabilities | 256.000 M | 808.000 M | 836.000 M | 865.000 M | 338.000 M | 339.000 M | 320.000 M | 361.000 M | |
| Current long term debt | 224.000 M | 161.000 M | 153.000 M | 187.000 M | 150.000 M | 0.000 | 0.000 | 0.000 | |
| Long term debt | 922.000 M | 912.000 M | 831.000 M | 843.000 M | 575.000 M | 575.000 M | 575.000 M | 576.000 M | |
| Other liabilities | 256.000 M | 808.000 M | 836.000 M | 865.000 M | 338.000 M | 339.000 M | 320.000 M | 361.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 17.992 B | 19.123 B | 18.863 B | 16.949 B | 13.455 B | 13.854 B | 12.817 B | 11.712 B | |
| Common stock | 390.000 M | 388.000 M | 386.000 M | 381.000 M | 381.000 M | 380.000 M | 382.000 M | 384.000 M | |
| Retained earnings | 16.855 B | 18.320 B | 18.399 B | 17.019 B | 13.389 B | 13.606 B | 12.431 B | 11.152 B |